Andrew Fein
Stock Analyst at HC Wainwright & Co.
(3.65)
# 803
Out of 4,915 analysts
611
Total ratings
46.8%
Success rate
7.45%
Average return
Main Sectors:
Stocks Rated by Andrew Fein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UTHR United Therapeutics | Maintains: Buy | $425 → $400 | $274.70 | +45.61% | 16 | Jul 31, 2025 | |
| FULC Fulcrum Therapeutics | Upgrades: Buy | $4 → $12 | $6.73 | +78.31% | 18 | Jul 29, 2025 | |
| KALV KalVista Pharmaceuticals | Reiterates: Buy | $27 | $13.63 | +98.17% | 16 | Jul 11, 2025 | |
| CADL Candel Therapeutics | Assumes: Buy | $23 | $6.45 | +256.87% | 1 | Jun 30, 2025 | |
| KYMR Kymera Therapeutics | Maintains: Buy | $54 → $60 | $43.74 | +37.17% | 8 | Jun 26, 2025 | |
| BIIB Biogen | Reiterates: Buy | $187 | $128.00 | +46.09% | 21 | Jun 26, 2025 | |
| ACAD ACADIA Pharmaceuticals | Reiterates: Buy | $32 | $23.83 | +34.31% | 20 | Jun 26, 2025 | |
| VRTX Vertex Pharmaceuticals | Reiterates: Buy | $550 | $456.87 | +20.38% | 27 | Jun 23, 2025 | |
| INSM Insmed | Maintains: Buy | $90 → $120 | $107.28 | +11.86% | 15 | Jun 11, 2025 | |
| PEPG PepGen | Maintains: Buy | $14 → $8 | $1.37 | +483.94% | 13 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $6 → $2 | $2.59 | -22.78% | 13 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $29 → $35 | $18.69 | +87.27% | 14 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $14 → $8 | $8.05 | -0.62% | 14 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $14 | $6.88 | +103.64% | 18 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $47 → $35 | $12.85 | +172.37% | 14 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $14 | $2.40 | +483.33% | 15 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $75 | $17.80 | +321.35% | 5 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $68 | $36.71 | +85.24% | 5 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $10 | $1.49 | +571.14% | 10 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $38 | $9.85 | +285.79% | 12 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $16 | $8.04 | +99.13% | 20 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $25 | $14.33 | +74.52% | 15 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $32 | $13.83 | +131.38% | 22 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $8.14 | +268.78% | 10 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $16 | $8.51 | +88.01% | 12 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $81 → $24 | $7.44 | +222.58% | 19 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $12 | $2.16 | +455.56% | 16 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $38 | $36.58 | +3.88% | 6 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $2.46 | +225.20% | 2 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $185 → $168 | $128.23 | +31.01% | 20 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $7 | $2.01 | +248.26% | 13 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $11 | $1.40 | +685.71% | 11 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.38 | +624.64% | 18 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $8.10 | +171.60% | 12 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 → $2 | $0.81 | +148.35% | 16 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $12 | $2.10 | +471.43% | 12 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $5.24 | +148.09% | 14 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $7.40 | +48.65% | 10 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $3.10 | +641.94% | 14 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.74 | +762.07% | 13 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $66.24 | +28.32% | 16 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $35 | $21.33 | +64.09% | 14 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $9.27 | +709.06% | 7 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $26.69 | +181.00% | 1 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $7 | $2.05 | +241.46% | 6 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $5.63 | +77.62% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $40 | $5.15 | +676.70% | 3 | Feb 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $0.88 | +16,945.45% | 1 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $200 → $60 | $14.52 | +313.22% | 4 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $15 | $4.99 | +200.60% | 1 | Apr 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $40 | $1.70 | +2,252.94% | 3 | Mar 16, 2022 |
United Therapeutics
Jul 31, 2025
Maintains: Buy
Price Target: $425 → $400
Current: $274.70
Upside: +45.61%
Fulcrum Therapeutics
Jul 29, 2025
Upgrades: Buy
Price Target: $4 → $12
Current: $6.73
Upside: +78.31%
KalVista Pharmaceuticals
Jul 11, 2025
Reiterates: Buy
Price Target: $27
Current: $13.63
Upside: +98.17%
Candel Therapeutics
Jun 30, 2025
Assumes: Buy
Price Target: $23
Current: $6.45
Upside: +256.87%
Kymera Therapeutics
Jun 26, 2025
Maintains: Buy
Price Target: $54 → $60
Current: $43.74
Upside: +37.17%
Biogen
Jun 26, 2025
Reiterates: Buy
Price Target: $187
Current: $128.00
Upside: +46.09%
ACADIA Pharmaceuticals
Jun 26, 2025
Reiterates: Buy
Price Target: $32
Current: $23.83
Upside: +34.31%
Vertex Pharmaceuticals
Jun 23, 2025
Reiterates: Buy
Price Target: $550
Current: $456.87
Upside: +20.38%
Insmed
Jun 11, 2025
Maintains: Buy
Price Target: $90 → $120
Current: $107.28
Upside: +11.86%
PepGen
May 29, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $1.37
Upside: +483.94%
May 29, 2025
Downgrades: Neutral
Price Target: $6 → $2
Current: $2.59
Upside: -22.78%
May 28, 2025
Maintains: Buy
Price Target: $29 → $35
Current: $18.69
Upside: +87.27%
May 27, 2025
Downgrades: Neutral
Price Target: $14 → $8
Current: $8.05
Upside: -0.62%
May 27, 2025
Maintains: Buy
Price Target: $30 → $14
Current: $6.88
Upside: +103.64%
May 14, 2025
Maintains: Buy
Price Target: $47 → $35
Current: $12.85
Upside: +172.37%
May 14, 2025
Maintains: Buy
Price Target: $20 → $14
Current: $2.40
Upside: +483.33%
May 12, 2025
Maintains: Buy
Price Target: $80 → $75
Current: $17.80
Upside: +321.35%
May 12, 2025
Maintains: Buy
Price Target: $72 → $68
Current: $36.71
Upside: +85.24%
May 9, 2025
Maintains: Buy
Price Target: $7 → $10
Current: $1.49
Upside: +571.14%
May 9, 2025
Maintains: Buy
Price Target: $46 → $38
Current: $9.85
Upside: +285.79%
May 9, 2025
Maintains: Buy
Price Target: $12 → $16
Current: $8.04
Upside: +99.13%
May 8, 2025
Maintains: Buy
Price Target: $40 → $25
Current: $14.33
Upside: +74.52%
May 7, 2025
Maintains: Buy
Price Target: $80 → $32
Current: $13.83
Upside: +131.38%
May 6, 2025
Reiterates: Buy
Price Target: $30
Current: $8.14
Upside: +268.78%
May 5, 2025
Maintains: Buy
Price Target: $7 → $16
Current: $8.51
Upside: +88.01%
May 2, 2025
Maintains: Buy
Price Target: $81 → $24
Current: $7.44
Upside: +222.58%
May 1, 2025
Maintains: Buy
Price Target: $16 → $12
Current: $2.16
Upside: +455.56%
Apr 30, 2025
Reiterates: Buy
Price Target: $38
Current: $36.58
Upside: +3.88%
Apr 28, 2025
Reiterates: Buy
Price Target: $8
Current: $2.46
Upside: +225.20%
Apr 22, 2025
Maintains: Buy
Price Target: $185 → $168
Current: $128.23
Upside: +31.01%
Apr 4, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $2.01
Upside: +248.26%
Mar 28, 2025
Maintains: Buy
Price Target: $15 → $11
Current: $1.40
Upside: +685.71%
Mar 27, 2025
Reiterates: Buy
Price Target: $10
Current: $1.38
Upside: +624.64%
Mar 26, 2025
Reiterates: Buy
Price Target: $22
Current: $8.10
Upside: +171.60%
Mar 17, 2025
Downgrades: Neutral
Price Target: $12 → $2
Current: $0.81
Upside: +148.35%
Mar 14, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $2.10
Upside: +471.43%
Mar 7, 2025
Reiterates: Buy
Price Target: $13
Current: $5.24
Upside: +148.09%
Mar 6, 2025
Reiterates: Buy
Price Target: $11
Current: $7.40
Upside: +48.65%
Mar 6, 2025
Reiterates: Buy
Price Target: $23
Current: $3.10
Upside: +641.94%
Mar 6, 2025
Reiterates: Buy
Price Target: $15
Current: $1.74
Upside: +762.07%
Mar 3, 2025
Reiterates: Buy
Price Target: $85
Current: $66.24
Upside: +28.32%
Feb 28, 2025
Reiterates: Buy
Price Target: $35
Current: $21.33
Upside: +64.09%
Feb 18, 2025
Reiterates: Buy
Price Target: $75
Current: $9.27
Upside: +709.06%
Jan 13, 2025
Reiterates: Buy
Price Target: $75
Current: $26.69
Upside: +181.00%
Nov 2, 2023
Maintains: Buy
Price Target: $17 → $7
Current: $2.05
Upside: +241.46%
Aug 15, 2023
Reiterates: Buy
Price Target: $10
Current: $5.63
Upside: +77.62%
Feb 13, 2023
Maintains: Buy
Price Target: $100 → $40
Current: $5.15
Upside: +676.70%
Jan 31, 2023
Reiterates: Buy
Price Target: $150
Current: $0.88
Upside: +16,945.45%
May 5, 2022
Downgrades: Neutral
Price Target: $200 → $60
Current: $14.52
Upside: +313.22%
Apr 27, 2022
Assumes: Buy
Price Target: $15
Current: $4.99
Upside: +200.60%
Mar 16, 2022
Maintains: Neutral
Price Target: $80 → $40
Current: $1.70
Upside: +2,252.94%